USPTO 2015–2025 USPTO PatentsView US Corporation

Dose Health Llc

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).

The verdict

According to USPTO PatentsView, Dose ranks #26,150 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,150
of 50,000 US assignees by volume
Top 65%
by Innovation Score (30.6/100)
10.1
avg claims per patent
+300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26150 · US Corporation #26,150 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,150/50,000
  • PHOTO-FINISH Dongguan Empress Tec…
  • CPC-NARROW A61J · 5 areas
  • INNOV-THIN 30.6/100
  • CLAIMS-PAR 10.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +300% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dongguan Empress Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Dose

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Dose's Innovation Score is 30.6/100 (top 65% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Dose's grants concentrate

Dose Health Llc is a focused PatentsView assignee: 5 CPC subclasses with 70% of grants classified under A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2018. By volume, Dose sits between Dongguan Empress Technology Co., Ltd. and Druggability Technologies IP Holdco Limited.

Dose's three-year grant acceleration

Dose Health Llc shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Dose's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Dose holds 10 patents at rank #26,163, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Dose

By rank, the assignees closest to #26,163 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Dose's primary technology class.

Dose's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 Top 65% higher than 35% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2018201920202021202220232024 2
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Dose Health Llc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 10.0%
2019 1 10.0%
2020 1 10.0%
2021 2 20.0%
2022 2 20.0%
2023 1 10.0%
2024 2 20.0%

Where it ranks

Overall rank by patents

#26,150

of 50,000 tracked assignees

Innovation Score

30.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.